Global footprint DFS I operates with a worldwide specimen collection footprint spanning over 100 countries, highlighting ongoing opportunities to expand contracted anti-doping services with both existing high-profile sports clients and international federations seeking scalable, compliant testing networks.

Proven partnerships Established relationships with major leagues and organizations (MLB, NFL, NBA, UFC, PGA Tour, LPGA, ITF, NCAA, CrossFit) demonstrate a track record of delivering trusted anti-doping programs, suggesting upsell potential in adjacent sports markets and deeper engagements with current clients.

Acquisition momentum Recent acquisition by CPC LLC signals potential for expanded sales channels, integrated offerings, and accelerated go-to-market strategies, creating new entry points for cross-sell with CPC’s portfolio and existing DFS I clients.

Regulatory leadership Participation in authoritative anti-doping and medication control initiatives (e.g., HISA ADMC program) positions DFS I as a compliance-first partner, appealing to organizations seeking robust governance, risk management, and accreditation in sports security programs.

Education and outreach DFS I’s health education and consumer platform initiatives indicate an opportunity to expand education-based services, certifications, and consumer-facing programs for teams, schools, and amateur federations looking to implement comprehensive integrity ecosystems.